Eye surgery showdown: which cornea transplant is safer?
NCT ID NCT04417959
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two types of cornea transplant surgery (DSAEK and DMEK) for people with Fuchs' endothelial dystrophy, a condition that clouds the cornea. Researchers measured vision and tracked side effects like swelling and eye pressure in 112 participants. The goal was to find out which method offers better vision and fewer complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUCHS ENDOTHELIAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Ophthalmology
Aarhus, Central Jutland, 8200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One shot to see clearly: cell therapy takes on corneal edema
- Built-In eye scanner could give surgeons a live 3D view during operations
- Could a 15-minute dip in your own blood save your cornea transplant?
- First human trial of Lab-Grown corneal implant launches
- Eye injection of special cells may reduce corneal swelling
- Eye drops could make fuchs surgery less invasive